https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-provides-clarifying-statement-elevidys
0
0
7/25/25 at 11:51pm
Organization
Sarepta.com
50 words
0
Comments
CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jul. 25, 2025-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: Just before 6:00 p.m. ET today, the U.S. Food and Drug Administrati…
You are the first to view
Create an account
or login to join the discussion